Pividl Bioscience Inc.
$75,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- June 1, 2025 – February 28, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q1-1031138
Published purpose
Pividl's Micellosomes are a novel nano-delivery system used to deliver hard to solubilize and poorly bioavailable compounds. This project is aimed at demonstrating how Micellosomes can be used to deliver anti-inflammatory molecules that have the potential to provide radiation protection and reduce the impacts of radiation / inflammation exposure on and in the human body. Formulations produced will be standardised and validated for stability, encapsulation efficiency and bioavailability kinetics in order to demonstrate their ability to prevent and reduce radiation induced inflammation in Microvascular endothelial cells and anti-inflammatory responses in human Embryonic kidney cells, cardiovascular cells and blood-brain-barrier cells.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.